These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1755 related articles for article (PubMed ID: 26269178)

  • 1. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
    Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
    J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
    Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
    J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
    Wang Y; Ye L; Wang X; Li J; Song L; Ho W
    Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
    Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
    Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
    Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection.
    Xiang Y; Tang JJ; Tao W; Cao X; Song BL; Zhong J
    J Virol; 2015 Jul; 89(13):6805-16. PubMed ID: 25903345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
    Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
    J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle.
    Kinast V; Plociennikowska A; Anggakusuma ; Bracht T; Todt D; Brown RJP; Boldanova T; Zhang Y; Brüggemann Y; Friesland M; Engelmann M; Vieyres G; Broering R; Vondran FWR; Heim MH; Sitek B; Bartenschlager R; Pietschmann T; Steinmann E
    J Hepatol; 2020 Sep; 73(3):549-558. PubMed ID: 32294532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate host response in primary human hepatocytes with hepatitis C virus infection.
    Yang D; Liu N; Zuo C; Lei S; Wu X; Zhou F; Liu C; Zhu H
    PLoS One; 2011; 6(11):e27552. PubMed ID: 22087337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
    Israelow B; Narbus CM; Sourisseau M; Evans MJ
    Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
    Qu L; Lemon SM
    Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.